RAEB
specificMyelodysplastic syndrome characterized by the presence of 5-9% blasts in bone marrow and 2-9% blasts in peripheral blood.
16
Centers
0
Active Trials
—
Cancer Funding
Top Centers for RAEB(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 53.1 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 53.1 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 53.1 |
| 4 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 53.1 |
| 5 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 53.1 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 53.1 |
| 7 | NCI Clinical | 53.1 |
| 8 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 53.1 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH | 53.1 |
| 10 | University of Illinois Cancer CenterChicago, IL | 53.1 |
| 11 | Boston University Cancer CenterBoston, MA | 53.1 |
| 12 | Cancer Center at IllinoisUrbana, IL | 53.1 |
| 13 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 53.1 |
| 14 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 53.1 |
| 15 | Cardinal Bernardin Cancer CenterMaywood, IL | 53.1 |
| 16 | Louisiana Cancer Research CenterNew Orleans, LA | 53.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →